UnknownPhase 2NCT02359474

Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin

Studying Soft tissue sarcoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ludwig-Maximilians - University of Munich
Principal Investigator
Rolf Issels, MD
Ludwig-Maximilians - University of Munich
Intervention
Trabectedin(drug)
Enrollment
120 target
Eligibility
18 years · All sexes
Timeline
20142023

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02359474 on ClinicalTrials.gov

Other trials for Soft tissue sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Soft tissue sarcoma

← Back to all trials